Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients

This study has been completed.
Information provided by:
Wakayama Medical University Identifier:
First received: August 19, 2008
Last updated: February 17, 2009
Last verified: February 2009
The aim of the study is to evaluate whether distal gastrectomy without post-operative nasogastric decompression tube is better in terms of quality of life.

Condition Intervention Phase
Gastric Cancer
Device: nasogastric tube
Device: without nasogastric tube
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Phase III Study for the Significance of Nasogastric Decompression Tube After Curative Distal Gastrectomy for Gastric Cancer Patients

Resource links provided by NLM:

Further study details as provided by Wakayama Medical University:

Primary Outcome Measures:
  • Quality of life [ Time Frame: seven days after operation ]

Secondary Outcome Measures:
  • complication, hematological data, [ Time Frame: the time of discharge ]

Enrollment: 180
Study Start Date: February 2006
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: A
Arm A: with nasogastric tube
Device: nasogastric tube
insertion of nasogastric tube for 2 days after operation
Active Comparator: B
Arm B: without nasogastric tube
Device: without nasogastric tube
without nasogastric tube after operation

Detailed Description:
Nasogastric decompression tube is an intra-operative routine in most of the time to facilitate exposure of operative field during elective distal gastrectomy, however, whether it should be retained post-operatively is controversial. Nasogastric decompression tube helps to drain the gastric remnant in case there is edema around the gastrojejunostomy, ileus and delayed gastric emptying, which can theoretically relieve nausea and abdominal distension. However, nasogastric intubation could cause patients discomfort; also it has been shown that it would cause gastroesophageal reflux which may be associated with pulmonary complication.

Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • on the basis of whether distal gastrectomy was anticipated at WMUH for gastric cancer.

Exclusion Criteria:

  • patients who were diagnosed inadequacy for this study by a physician.
  • patients without an informed consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00738478

Second Department of Surgery, Wakayama Medical University
Wakayama, Japan, 641-8510
Sponsors and Collaborators
Wakayama Medical University
Principal Investigator: Mikihito Nakamori, MD Wakayama Medical University
  More Information

Responsible Party: Second Department of Surgery, Wakayama Medical University Identifier: NCT00738478     History of Changes
Other Study ID Numbers: WMC-RCTGastric01
Study First Received: August 19, 2008
Last Updated: February 17, 2009

Keywords provided by Wakayama Medical University:
distal gastrectomy
quality of life

Additional relevant MeSH terms:
Stomach Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases processed this record on May 22, 2017